TWP
HRMY icon

TFO Wealth Partners’s Harmony Biosciences HRMY Stock Holding History

TFO Wealth Partners’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1
Closed -$34 – 376
2024
Q1 		$34 Hold
1
– – ﹤0.01% 745
2023
Q4 		$32 Hold
1
– – ﹤0.01% 894
2023
Q3 		$35 Hold
1
– – ﹤0.01% 1064
2023
Q2 		$35 Hold
1
– – ﹤0.01% 786
2023
Q1 		$33 Sell
1
-26
-96% -$1.18K ﹤0.01% 770
2022
Q4 		$1.12K Buy
+27
New +$1.49K ﹤0.01% 342

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TFO Wealth Partners's HRMY Position: Q2 2024 in Review

TFO Wealth Partners sold out of Harmony Biosciences (HRMY) in Q2 2024, closing a stake of 1 share — an estimated $34 sold.

TFO Wealth Partners first reported a position in HRMY in Q4 2022 and held it in 6 quarters. The position peaked at $1.12K in Q4 2022. 219 funds tracked by Wall St. Rank hold HRMY as of Q2 2024.

  • TFO Wealth Partners reported no remaining Harmony Biosciences position as of Q2 2024 after selling out during the quarter.
  • TFO Wealth Partners sold 1 Harmony Biosciences share in Q2 2024, an estimated $34.
  • TFO Wealth Partners first reported a position in Harmony Biosciences in Q4 2022 and held it in 6 quarters.
  • TFO Wealth Partners's Harmony Biosciences position peaked at $1.12K in Q4 2022.
  • 219 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2024.

Based on TFO Wealth Partners's 13F filing for Q2 2024, filed 15 Aug 2024.